AURA BIOSCIENCES INC (AURA) Fundamental Analysis & Valuation

NASDAQ:AURA • US05153U1079

Current stock price

6.78 USD
+0.01 (+0.15%)
At close:
6.78 USD
0 (0%)
After Hours:

This AURA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. AURA Profitability Analysis

1.1 Basic Checks

  • AURA had negative earnings in the past year.
  • AURA had a negative operating cash flow in the past year.
  • AURA had negative earnings in each of the past 5 years.
  • AURA had a negative operating cash flow in each of the past 5 years.
AURA Yearly Net Income VS EBIT VS OCF VS FCFAURA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M -80M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -62.68%, AURA is doing worse than 61.12% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -77.56%, AURA is in line with its industry, outperforming 50.10% of the companies in the same industry.
Industry RankSector Rank
ROA -62.68%
ROE -77.56%
ROIC N/A
ROA(3y)-46.75%
ROA(5y)-39.07%
ROE(3y)-56.2%
ROE(5y)-45.79%
ROIC(3y)N/A
ROIC(5y)N/A
AURA Yearly ROA, ROE, ROICAURA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150

1.3 Margins

  • AURA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AURA Yearly Profit, Operating, Gross MarginsAURA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. AURA Health Analysis

2.1 Basic Checks

  • AURA has more shares outstanding than it did 1 year ago.
  • AURA has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for AURA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
AURA Yearly Shares OutstandingAURA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
AURA Yearly Total Debt VS Total AssetsAURA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

  • An Altman-Z score of 2.78 indicates that AURA is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.78, AURA is in the better half of the industry, outperforming 67.50% of the companies in the same industry.
  • There is no outstanding debt for AURA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.78
ROIC/WACCN/A
WACCN/A
AURA Yearly LT Debt VS Equity VS FCFAURA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

2.3 Liquidity

  • A Current Ratio of 8.15 indicates that AURA has no problem at all paying its short term obligations.
  • AURA has a better Current ratio (8.15) than 71.95% of its industry peers.
  • A Quick Ratio of 8.15 indicates that AURA has no problem at all paying its short term obligations.
  • With a decent Quick ratio value of 8.15, AURA is doing good in the industry, outperforming 72.15% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.15
Quick Ratio 8.15
AURA Yearly Current Assets VS Current LiabilitesAURA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. AURA Growth Analysis

3.1 Past

  • AURA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.86%.
EPS 1Y (TTM)-10.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, AURA will show a small growth in Earnings Per Share. The EPS will grow by 2.61% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-14.24%
EPS Next 2Y3.25%
EPS Next 3Y1.05%
EPS Next 5Y2.61%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AURA Yearly Revenue VS EstimatesAURA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
AURA Yearly EPS VS EstimatesAURA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 -1 -2 -3 -4

More info and screens

Find the best growth stocksShow best growing peers

0

4. AURA Valuation Analysis

4.1 Price/Earnings Ratio

  • AURA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AURA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AURA Price Earnings VS Forward Price EarningsAURA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AURA Per share dataAURA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.25%
EPS Next 3Y1.05%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AURA Dividend Analysis

5.1 Amount

  • No dividends for AURA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AURA Fundamentals: All Metrics, Ratios and Statistics

AURA BIOSCIENCES INC

NASDAQ:AURA (4/9/2026, 8:12:48 PM)

After market: 6.78 0 (0%)

6.78

+0.01 (+0.15%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-30
Earnings (Next)05-07
Inst Owners77.37%
Inst Owner Change0%
Ins Owners1.8%
Ins Owner Change19.23%
Market Cap434.94M
Revenue(TTM)N/A
Net Income(TTM)-106.19M
Analysts83.33
Price Target18.87 (178.32%)
Short Float %4.42%
Short Ratio10.55
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.66%
Min EPS beat(2)-19.25%
Max EPS beat(2)15.94%
EPS beat(4)1
Avg EPS beat(4)-3.45%
Min EPS beat(4)-19.25%
Max EPS beat(4)15.94%
EPS beat(8)4
Avg EPS beat(8)0.97%
EPS beat(12)7
Avg EPS beat(12)0.39%
EPS beat(16)9
Avg EPS beat(16)0.07%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.18
P/tB 3.18
EV/EBITDA N/A
EPS(TTM)-1.94
EYN/A
EPS(NY)-1.63
Fwd EYN/A
FCF(TTM)-1.33
FCFYN/A
OCF(TTM)-1.32
OCFYN/A
SpS0
BVpS2.13
TBVpS2.13
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -62.68%
ROE -77.56%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-46.75%
ROA(5y)-39.07%
ROE(3y)-56.2%
ROE(5y)-45.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 39.59%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.15
Quick Ratio 8.15
Altman-Z 2.78
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)65.6%
Cap/Depr(5y)109.16%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y-14.24%
EPS Next 2Y3.25%
EPS Next 3Y1.05%
EPS Next 5Y2.61%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-6.19%
OCF growth 3YN/A
OCF growth 5YN/A

AURA BIOSCIENCES INC / AURA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for AURA BIOSCIENCES INC?

ChartMill assigns a fundamental rating of 2 / 10 to AURA.


What is the valuation status for AURA stock?

ChartMill assigns a valuation rating of 0 / 10 to AURA BIOSCIENCES INC (AURA). This can be considered as Overvalued.


What is the profitability of AURA stock?

AURA BIOSCIENCES INC (AURA) has a profitability rating of 0 / 10.


What is the financial health of AURA BIOSCIENCES INC (AURA) stock?

The financial health rating of AURA BIOSCIENCES INC (AURA) is 7 / 10.


What is the expected EPS growth for AURA BIOSCIENCES INC (AURA) stock?

The Earnings per Share (EPS) of AURA BIOSCIENCES INC (AURA) is expected to decline by -14.24% in the next year.